La bourse ferme dans 41 min
  • CAC 40

    6 217,23
    +52,12 (+0,85 %)
     
  • Euro Stoxx 50

    3 979,73
    +39,27 (+1,00 %)
     
  • Dow Jones

    33 998,06
    +176,76 (+0,52 %)
     
  • EUR/USD

    1,2024
    -0,0017 (-0,14 %)
     
  • Gold future

    1 794,40
    +16,00 (+0,90 %)
     
  • BTC-EUR

    46 709,80
    -339,98 (-0,72 %)
     
  • CMC Crypto 200

    1 292,63
    +29,67 (+2,35 %)
     
  • Pétrole WTI

    62,18
    -0,49 (-0,78 %)
     
  • DAX

    15 191,47
    +61,96 (+0,41 %)
     
  • FTSE 100

    6 906,97
    +47,10 (+0,69 %)
     
  • Nasdaq

    13 828,41
    +42,14 (+0,31 %)
     
  • S&P 500

    4 150,46
    +15,52 (+0,38 %)
     
  • Nikkei 225

    28 508,55
    -591,83 (-2,03 %)
     
  • HANG SENG

    28 621,92
    -513,81 (-1,76 %)
     
  • GBP/USD

    1,3937
    +0,0000 (+0,00 %)
     

Antipsychotic Drugs Market Research Report by Class, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19

ReportLinker
·5 min de lecture

Antipsychotic Drugs Market Research Report by Class (First Generation, Second Generation, and Third generation), by Application (Bipolar disorders, Dementia, Schizophrenia, and Unipolar Depression) - Global Forecast to 2025 - Cumulative Impact of COVID-19

New York, March 11, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Antipsychotic Drugs Market Research Report by Class, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06034061/?utm_source=GNW

Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Antipsychotic Drugs Market is expected to grow from USD 7,729.88 Million in 2020 to USD 10,835.86 Million by the end of 2025.
2. The Global Antipsychotic Drugs Market is expected to grow from EUR 6,777.70 Million in 2020 to EUR 9,501.08 Million by the end of 2025.
3. The Global Antipsychotic Drugs Market is expected to grow from GBP 6,025.39 Million in 2020 to GBP 8,446.48 Million by the end of 2025.
4. The Global Antipsychotic Drugs Market is expected to grow from JPY 824,974.55 Million in 2020 to JPY 1,156,460.84 Million by the end of 2025.
5. The Global Antipsychotic Drugs Market is expected to grow from AUD 11,224.82 Million in 2020 to AUD 15,735.10 Million by the end of 2025.

Market Segmentation & Coverage:
This research report categorizes the Antipsychotic Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Class, the Antipsychotic Drugs Market studied across First Generation, Second Generation, and Third generation. The First Generation further studied across Haldo and Navane. The Second Generation further studied across Geodon, Invega, Latuda, Risperdal, Seroquel, and Zyprexa. The Third generation further studied across Abilify.

Based on Application, the Antipsychotic Drugs Market studied across Bipolar disorders, Dementia, Schizophrenia, and Unipolar Depression.

Based on Geography, the Antipsychotic Drugs Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Antipsychotic Drugs Market including Alkermes PLC, Allergan PLC, AMBOSS GmbH, AstraZeneca PLC, Bristol-Myers Squibb Company, Daiichi Sankyo Co. Ltd., Dr. Reddy’s Laboratories, Ltd., Eli Lilly & Co., F.Hoffmann-La Roche AG, Flagship Biotech International Pvt. Ltd, GlaxoSmithKline PLC, H. Lundbeck A/S, Karger AG, Luye Pharma Group, Merck & Co., Inc., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Pfizer, Inc., Questex LLC, Sumitomo Dainippon Pharma Co., Ltd., Teva Pharmaceutical Industries, Ltd., The Medicines Co., and Vanda Pharmaceuticals Inc..

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Antipsychotic Drugs Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Antipsychotic Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Antipsychotic Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Antipsychotic Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Antipsychotic Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Antipsychotic Drugs Market?
6. What are the modes and strategic moves considered suitable for entering the Global Antipsychotic Drugs Market?
Read the full report: https://www.reportlinker.com/p06034061/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001